Valuation (28%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -0.98 | 16.28 |
| PEG Ratio (TTM) | 0.00 | -22.42 |
| P/S Ratio (TTM) | N/A | 5.35 |
| P/B Ratio (TTM) | 0.51 | 4.49 |
| P/FCF Ratio (TTM) | -0.25 | 7.69 |
| Price to 5YR AVG Earnings Ratio | -0.54 | 27.48 |
| Price to 5YR AVG FCF Ratio | -0.24 | 20.63 |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -43.93% | 2.47% |
| ROE (TTM) | -47.64% | 24.40% |
| Net Profit Margin (TTM) | N/A | -13.02% |
| ROIC 5YR AVG | -291.40% | 9.62% |
Growth (18%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -158.40% | 8.97% | -17.84% |
| Revenue | N/A | -33.33% | -59.73% |
| Net Income | -21.84% | -6.24% | -29.74% |
| Cash Flow | 6.65% | 7.00% | -13.69% |
Health (46%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 15.33 | 2.50 |
| Quick Ratio (TTM) | 15.06 | 1.86 |
| D/E Ratio (TTM) | 0.14 | -0.12 |
| Interest Coverage (TTM) | 330.62 | 11.81 |
| Piotroski F-Score | 2 | 6 |
| Altman Z-Score | N/A | 4.63 |
| LTL to 5YR AVG FCF | -0.31 | 4.67 |
| Shares Outstanding Growth 5YR AVG | 6.65% | 29.87% |